| Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers CR Jack, DS Knopman, WJ Jagust, RC Petersen, MW Weiner, PS Aisen, ... The lancet neurology 12 (2), 207-216, 2013 | 4604 | 2013 |
| Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance Y Stern, EM Arenaza‐Urquijo, D Bartrés‐Faz, S Belleville, M Cantilon, ... Alzheimer's & Dementia 16 (9), 1305-1311, 2020 | 1358 | 2020 |
| Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences MM Mielke, P Vemuri, WA Rocca Clinical epidemiology, 37-48, 2014 | 1127 | 2014 |
| Defining imaging biomarker cut points for brain aging and Alzheimer's disease CR Jack Jr, HJ Wiste, SD Weigand, TM Therneau, VJ Lowe, DS Knopman, ... Alzheimer's & Dementia 13 (3), 205-216, 2017 | 797 | 2017 |
| An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease CR Jack Jr, DS Knopman, SD Weigand, HJ Wiste, P Vemuri, V Lowe, ... Annals of neurology 71 (6), 765-775, 2012 | 691 | 2012 |
| Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease CR Jack Jr, HJ Wiste, P Vemuri, SD Weigand, ML Senjem, G Zeng, ... Brain 133 (11), 3336-3348, 2010 | 617 | 2010 |
| Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies P Vemuri, JL Gunter, ML Senjem, JL Whitwell, K Kantarci, DS Knopman, ... Neuroimage 39 (3), 1186-1197, 2008 | 577 | 2008 |
| Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau-and amyloid-positron emission tomography MM Mielke, CE Hagen, J Xu, X Chai, P Vemuri, VJ Lowe, DC Airey, ... Alzheimer's & Dementia 14 (8), 989-997, 2018 | 562 | 2018 |
| Cascading network failure across the Alzheimer’s disease spectrum DT Jones, DS Knopman, JL Gunter, J Graff-Radford, P Vemuri, BF Boeve, ... Brain 139 (2), 547-562, 2016 | 534 | 2016 |
| MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change P Vemuri, HJ Wiste, SD Weigand, LM Shaw, JQ Trojanowski, MW Weiner, ... Neurology 73 (4), 294-301, 2009 | 489 | 2009 |
| Non-stationarity in the “resting brain’s” modular architecture DT Jones, P Vemuri, MC Murphy, JL Gunter, ML Senjem, MM Machulda, ... PloS one 7 (6), e39731, 2012 | 485 | 2012 |
| MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study JL Whitwell, KA Josephs, ME Murray, K Kantarci, SA Przybelski, ... Neurology 71 (10), 743-749, 2008 | 468 | 2008 |
| Brain β-amyloid load approaches a plateau CR Jack Jr, HJ Wiste, TG Lesnick, SD Weigand, DS Knopman, P Vemuri, ... Neurology 80 (10), 890-896, 2013 | 438 | 2013 |
| Age, sex, and APOE ε4 effects on memory, brain structure, and β-amyloid across the adult life span CR Jack, HJ Wiste, SD Weigand, DS Knopman, P Vemuri, MM Mielke, ... JAMA neurology 72 (5), 511-519, 2015 | 437 | 2015 |
| Longitudinal tau PET in ageing and Alzheimer’s disease CR Jack Jr, HJ Wiste, CG Schwarz, VJ Lowe, ML Senjem, P Vemuri, ... Brain 141 (5), 1517-1528, 2018 | 435 | 2018 |
| Neuroimaging standards for research into small vessel disease—advances since 2013 M Duering, GJ Biessels, A Brodtmann, C Chen, C Cordonnier, ... The Lancet Neurology 22 (7), 602-618, 2023 | 424 | 2023 |
| Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 BF Boeve, KB Boylan, NR Graff-Radford, M DeJesus-Hernandez, ... Brain 135 (3), 765-783, 2012 | 418 | 2012 |
| Age-related changes in the default mode network are more advanced in Alzheimer disease DT Jones, MM Machulda, P Vemuri, EM McDade, G Zeng, ML Senjem, ... Neurology 77 (16), 1524-1531, 2011 | 418 | 2011 |
| White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities J Alber, S Alladi, HJ Bae, DA Barton, LA Beckett, JM Bell, SE Berman, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 408 | 2019 |
| Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study CR Jack, HJ Wiste, SD Weigand, WA Rocca, DS Knopman, MM Mielke, ... The Lancet Neurology 13 (10), 997-1005, 2014 | 398 | 2014 |
Matthew L. SenjemAssistant Professor of Radiology, Mayo Clinic College of MedicineПідтверджена електронна адреса в mayo.edu